<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>159</volume><submitter>Haeusler GM</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>There are limited data on SARS-CoV-2 (COVID-19) infection in children with cancer or after haematopoietic stem cell transplant (HSCT). We describe the severity and outcomes of SARS-COV-2 in these patients and identify factors associated with severe disease.&lt;h4>Methods&lt;/h4>This was a multinational, observational study of children (aged &lt;19 years) with cancer or HSCT and SARS-CoV-2 confirmed by polymerase chain reaction. COVID-19 was classified as asymptomatic, mild, moderate, severe or critical (≥1 organ support). Exact polytomous regression was used to determine the relationship between clinical variables and disease severity.&lt;h4>Results&lt;/h4>One hundred and thirty-one patients with COVID-19 across 10 countries were identified (median age 8 years). Seventy-eight (60%) had le</pubmed_abstract><journal>European journal of cancer (Oxford, England : 1990)</journal><pagination>78-86</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8501219</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients.</pubmed_title><pmcid>PMC8501219</pmcid><pubmed_authors>Ammann RA</pubmed_authors><pubmed_authors>Attarbaschi A</pubmed_authors><pubmed_authors>Sung L</pubmed_authors><pubmed_authors>Groll AH</pubmed_authors><pubmed_authors>Gilli F</pubmed_authors><pubmed_authors>Wegehaupt O</pubmed_authors><pubmed_authors>Speckmann C</pubmed_authors><pubmed_authors>Carlesse F</pubmed_authors><pubmed_authors>Solopova G</pubmed_authors><pubmed_authors>Averbuch D</pubmed_authors><pubmed_authors>Agyeman PKA</pubmed_authors><pubmed_authors>Lehrnbecher T</pubmed_authors><pubmed_authors>Phillips B</pubmed_authors><pubmed_authors>Haeusler GM</pubmed_authors><pubmed_authors>Castagnola E</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients.</name><description>&lt;h4>Purpose&lt;/h4>There are limited data on SARS-CoV-2 (COVID-19) infection in children with cancer or after haematopoietic stem cell transplant (HSCT). We describe the severity and outcomes of SARS-COV-2 in these patients and identify factors associated with severe disease.&lt;h4>Methods&lt;/h4>This was a multinational, observational study of children (aged &lt;19 years) with cancer or HSCT and SARS-CoV-2 confirmed by polymerase chain reaction. COVID-19 was classified as asymptomatic, mild, moderate, severe or critical (≥1 organ support). Exact polytomous regression was used to determine the relationship between clinical variables and disease severity.&lt;h4>Results&lt;/h4>One hundred and thirty-one patients with COVID-19 across 10 countries were identified (median age 8 years). Seventy-eight (60%) had le</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-20T00:26:57.845Z</modification><creation>2022-02-11T13:25:03.633Z</creation></dates><accession>S-EPMC8501219</accession><cross_references><pubmed>34736044</pubmed><doi>10.1016/j.ejca.2021.09.027</doi></cross_references></HashMap>